by Jean-Marc Ferran | Aug 29, 2019 | Blog
What did the FDA put forward to enhance Transparency? Background On 16. January 2018, FDA Commissioner, Scott Gottlieb announced the FDA’s intention to evaluate how they could share Clinical Documents of Pivotal Phase III studies following a successful... by Jean-Marc Ferran | Aug 16, 2019 | News
Meet us at the PHUSE Utrecht SDE 2019 on 10 October Jean-Marc Ferran will be presenting with Bjarke Klein (Ferring Pharmaceuticals) on implementing a Life Cycle Management process for programs in LSAF on Thursday, 10 October: Managing Program Development Life...
Recent Comments